MEDICLIN Aktiengesellschaft (ETR:MED)
Germany · Delayed Price · Currency is EUR 5.45
0.00 (0.00%)
Aug 26, 2026, 5:35 PM CET
ETR:MED Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 29.11 | 25.49 | 24.84 | -10.78 | 9.44 | 1.46 |
Depreciation & Amortization | 53.29 | 52.3 | 50.28 | 52.28 | 71.4 | 73.64 |
Loss (Gain) From Sale of Assets | -0.67 | -0.11 | -0.23 | -0.05 | -0.24 | -0.09 |
Asset Writedown & Restructuring Costs | 7.92 | 7.92 | - | 33.73 | - | 0.02 |
Other Operating Activities | 15.88 | 27.76 | 26.68 | 28.13 | 3.53 | 5.21 |
Change in Other Net Operating Assets | -7.58 | -10.92 | -21.01 | -25.31 | -49.5 | 1.73 |
Operating Cash Flow | 97.94 | 102.44 | 80.57 | 78 | 34.64 | 81.97 |
Operating Cash Flow Growth | 4.92% | 27.15% | 3.29% | 125.18% | -57.74% | -30.94% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -41.98 | -48.43 | -38.04 | -34.42 | -24.37 | -15.23 |
Sale of Property, Plant & Equipment | 0.94 | 0.31 | 0.97 | 0.47 | 0.67 | 0.29 |
Divestitures | - | - | 9.5 | 8.65 | - | - |
Sale (Purchase) of Intangibles | -4.1 | -3 | -6.65 | -3.16 | -1.65 | -1.78 |
Investment in Securities | -0.1 | -0.1 | -0.01 | -0.04 | -0.04 | -0.04 |
Other Investing Activities | 24.5 | 14.08 | 19.1 | 18.99 | 19.14 | 9.66 |
Investing Cash Flow | -20.74 | -37.14 | -15.13 | -9.51 | -6.24 | -7.09 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -77.11 | -50.38 | -23.65 | -46.1 | -46.97 |
Net Debt Issued (Repaid) | -77.68 | -77.11 | -50.38 | -23.65 | -46.1 | -46.97 |
Common Dividends Paid | -1.9 | -1.9 | - | - | - | - |
Other Financing Activities | -19.49 | -20.97 | -22.78 | -21.83 | -10.07 | -8.3 |
Financing Cash Flow | -99.07 | -99.97 | -73.16 | -45.48 | -56.17 | -55.26 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -21.86 | -34.67 | -7.73 | 23.01 | -27.77 | 19.62 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 55.96 | 54.01 | 42.52 | 43.58 | 10.27 | 66.74 |
Free Cash Flow Growth | 11.21% | 27.02% | -2.43% | 324.41% | -84.61% | -30.80% |
Free Cash Flow Margin | 6.83% | 6.74% | 5.58% | 5.72% | 1.43% | 9.76% |
Free Cash Flow Per Share | 1.18 | 1.14 | 0.90 | 0.92 | 0.22 | 1.41 |
Levered Free Cash Flow | 17.74 | 9.14 | 42.66 | 15.77 | 7.02 | 50.92 |
Unlevered Free Cash Flow | 29.87 | 22.14 | 56.85 | 29.84 | 13.33 | 56.58 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 19.49 | 20.97 | 22.78 | 21.83 | 10.07 | 8.3 |
Cash Income Tax Paid | 13.43 | 2.28 | 3.02 | -2.83 | 3.24 | 2.37 |
Change in Working Capital | -7.58 | -10.92 | -21.01 | -25.31 | -49.5 | 1.73 |